217 results on '"Cvek, Jakub"'
Search Results
2. Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study
3. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
4. Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses
5. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
6. Efficacy and Safety of Stereotactic Radiotherapy in Patients With Recurrent Ventricular Tachycardias: The Czech Experience
7. A Framework for Assessing the Effect of Cardiac and Respiratory Motion for Stereotactic Arrhythmia Radioablation Using a Digital Phantom With a 17-Segment Model: A STOPSTORM.eu Consortium Study
8. Longitudinal analysis of T2 relaxation time variations following radiotherapy for prostate cancer
9. Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium
10. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
11. Stereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review
12. Inflammation and fibrosis characterize different stages of myocardial remodeling in patients after stereotactic body radiotherapy of ventricular myocardium for recurrent ventricular tachycardia
13. Stereotactic Radiotherapy in the Management of Ventricular Tachycardias: More Questions than Answers?
14. Radiation-Induced Changes in Ventricular Myocardium After Stereotactic Body Radiotherapy for Recurrent Ventricular Tachycardia
15. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
16. A Framework for Assessing the Effect of Cardiac and Respiratory Motion for Stereotactic Arrhythmia Radioablation Using a Digital Phantom With a 17-Segment Model: A STOPSTORM.eu Consortium Study
17. Hypertrophic obstructive cardiomyopathy with recurrent ventricular tachycardias: from catheter ablation and stereotactic radiotherapy to heart transplant—a case report.
18. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement
19. Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost
20. A Proposal of Measuring Telemetry System for Patient Breathing Recording within Radiotherapy
21. Optimized target delineation procedure for the radiosurgery treatment of ventricular tachycardia: observer-independent accuracy.
22. High PD-L1 expression on immune cells along with increased density of tumor-infiltrating lymphocytes predicts a favorable survival outcome for patients with loco-regionally advanced head and neck cancer: early results from a prospective study.
23. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
24. Stereotactic body radiation therapy in the treatment of early-stage non-small cell lung cancer
25. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
26. 1397: Treatment outcomes comparison of posterior pharyngeal wall cancers from oropharynx and hypopharynx.
27. 1217: Cardiac substructure auto-contouring for ventricular tachycardia patients: a STOPSTORM.eu study
28. A framework for assessing the impact of cardiac and respiratory motion for STereotactic Arrhythmia Radioablation (STAR) using a digital phantom with a 17-segment model - A STOPSTORM.eu consortium study
29. Repeated stereotactic radiotherapy of recurrent ventricular tachycardia
30. PO-05-093 STEREOTACTIC RADIOTHERAPY FOR REFRACTORY VENTRICULAR TACHYCARDIA LEADS TO PROLONGATION OF ARRHYTHMIA CYCLE LENGTH
31. Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer
32. https://www.prolekare.cz/en/journals/transfusion-and-haematology-today/2023-1-15/recommendations-for-thrombotic-risk-stratification-and-targeted-thromboprophylaxis-in-women-during-assisted-reproduction-133823
33. Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium
34. Stereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review
35. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
36. Refining Critical Structure Contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark Results and Consensus Guidelines from the STOPSTORM.eu Consortium
37. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
38. Analysis of Lung Tumor Motion in a Large Sample: Patterns and Factors Influencing Precise Delineation of Internal Target Volume
39. A single reference measurement can predict liver tumor motion during respiration
40. HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy
41. The influence of excessive stress on the quality of life of medical students in the Czech Republic – National sample
42. Prognostic and predictive factors of brain meningiomas
43. Skin care of patients undergoing radiotherapy
44. Oncology wounds – recommendations for care based on multidisciplinary cooperation
45. Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study
46. Péče o kůži u pacientů podstupujících radioterapii.
47. Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer
48. Does Endoscopic Transnasal Optic Nerve Decompression Followed by Radiosurgery Improve Outcomes in the Treatment of Parasellar Meningiomas?
49. FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
50. Stereotactic Ablative Radiotherapy of Ventricular Tachycardia Using Tracking: Optimized Target Definition Workflow
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.